Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The ENDOMETRIAL Study: EvaluatioN of DNA methylatiOn Markers for EndomeTrial Cancer Risk-stratification Using Patient-collected urIne and vAginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal bLeeding

NCT07400835 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT07400835
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07400835 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The ENDOMETRIAL Study: EvaluatioN of DNA methylatiOn Markers for EndomeTrial Cancer Risk-stratification Using Patient-collected urIne and vAginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal bLeeding
Lead sponsor
University of Aarhus
Phase
Observational
Overall status
Recruiting
Start date
February 24, 2026
Completion date
February 24, 2030
Enrollment
600 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal bleeding